Cargando…
Views of primary care physicians and rheumatologists regarding screening and treatment of hyperlipidemia among patients with rheumatoid arthritis
BACKGROUND: Despite high risk for cardiovascular disease (CVD) mortality, screening and treatment of hyperlipidemia in patients with rheumatoid arthritis (RA) is suboptimal. We asked primary care physicians (PCPs) and rheumatologists to identify barriers to screening and treatment for hyperlipidemia...
Autores principales: | Navarro-Millán, Iris, Cornelius-Schecter, Anna, O’Beirne, Ronan J., Morris, Melanie S., Lui, Geyanne E., Goodman, Susan M., Cherrington, Andrea L., Fraenkel, Liana, Curtis, Jeffrey R., Safford, Monika M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057468/ https://www.ncbi.nlm.nih.gov/pubmed/32159074 http://dx.doi.org/10.1186/s41927-020-0112-5 |
Ejemplares similares
-
Which patient reported outcome domains are important to the rheumatologists while assessing patients with rheumatoid arthritis?
por: Jagpal, Aprajita, et al.
Publicado: (2019) -
Barriers and facilitators for screening and treatment of hyperlipidemia among patients with inflammatory arthritis
por: Navarro-Millán, Iris, et al.
Publicado: (2020) -
Evaluation of an Intervention to Support Patient‐Rheumatologist Conversations About Escalating Treatment in Patients with Rheumatoid Arthritis: A Proof‐of‐Principle Study
por: Danila, Maria I., et al.
Publicado: (2021) -
Protocol for the pilot randomized trial of the CArdiovascular Risk assEssment for Rheumatoid Arthritis (CARE RA) intervention: a peer coach behavioral intervention
por: Weiner, Joan, et al.
Publicado: (2022) -
Rheumatologist and Patient Mental Models for Treatment of Rheumatoid Arthritis Help Explain Low Treat‐to‐Target Rates
por: Hsiao, Betty, et al.
Publicado: (2022)